Xeris Biopharma | Investor Presentation Deck | 11 slides · page 8 of 11
Clinical trial data (XP-8121-108) comparing subcutaneous (SC) vs oral (PO) administration.
Pitch deck · traction · analyze_data · balanced density
Slide locked Sign in to view
Slide schematic 3/3
chart 1/1 list 1/1 title 1/1
Components 3
line bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.